Dr. Ranbir Chander (RC) Sobti is Emeritus Professor at Punjab University, Chandigarh, and Honorary Scientist at the Indian National Science Academy. He started his career as a cytogeneticist and progressed to molecular biology and disease processes of cancer, COPD, AIDS, metabolic syndrome, and kidney diseases. He is a Fellow of the Third World Academy of Sciences, National Academy of Sciences India, Indian National Science Academy, National Academy of Medical Sciences, National Academy of Agricultural Sciences, Canadian Academy of Cardiovascular Diseases Royal Society of biology and international Association of Cancer Research. Dr. Sobti has participated in several book projects, including Elsevier’s Advances in Animal Experimentation and Modeling; Biomarkers in Cancer Detection and Monitoring of Therapeutics; Molecular Medicine and Biomedical Research in the Era of Precision Medicine; One Planet, One Health, One Future; Probiotics; and Public and Environmental Health. Aastha Sobti is a Doctoral student at the Department of Immunotechnology at Lund University, Sweden. Her research areas interests include translational medicine, clinical dentistry, cancer immunology, biomarkers, diagnostics and medical oncology. Aastha Sobti has written two books with Elsevier: "Biomarkers in Cancer Detection and Monitoring of Therapeutics" (2023) and Molecular Medicine and Biomedical Research in the Era of Precision Medicine (2025). Dr. Jagmohan Singh holds a Ph.D. in Biotechnology and Cancer Genomics from Punjab University, Chandigarh, India. He is currently serving as an adjunct faculty in Anatomy and Physiology at Thomas Jefferson University in Philadelphia, Pennsylvania. He has made significant contribution in Gastric Physiology and Pharmacology. His current research focus is on cancer immunotherapy and vaccine development against cancer recurrence. Dr. Singh's teaching and research experience has provided him with valuable insights into reviewing and editing scientific papers, review articles and book chapters, with diverse scientific aims. His research findings have been published in numerous internationally reputed journals. He has also made substantial contributions to cancer immunotherapy, including vaccine production, quality control, and clinical trials. As a multifaceted professional with a robust background in research, education, and administration, Dr. Singh’s contributions will be highly insightful to fulfilling the purpose of this book. Harpal S. Buttar, PhD, is Adjunct Professor in the Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of Ottawa, Canada, and also serves as Visiting Professor at Guru Nanak Dev University, India, and Honorary Professor at Amity University, India. He previously worked for more than four decades as a Senior Research Scientist and Assessment Officer in the Therapeutic Products Directorate of Health Canada. His research and professional interests include pharmacology, nutrition, functional foods, dietary interventions, lifestyle approaches to the prevention of cardiovascular disease, obesity, and diabetes, and the safety of drug interactions with herbal products and fruit juices. Dr. Buttar has contributed extensively to biomedical research through scholarly publications, book chapters, and international collaborations. He has served on the editorial boards of scientific journals, acted as an external examiner for postgraduate research degrees, and delivered invited lectures and seminars internationally. He is a Fellow of the International College of Nutrition and the International Academy of Cardiovascular Sciences.

Select Guide Rating

• VOLUME 1: INTEGRATING MODERN HEALTH TECHNOLOGIES AND TRADITIONAL THERAPIES TO PROMOTE GOOD HEALTHSECTION 1: BIOTECHNOLOGICAL INNOVATIONS FOR SUSTAINABLE DEVELOPMENT TOWARDS GOOD HEALTH CARE SYSTEM1. ADVANCED TECHNOLOGIES FOR DISEASE INTERVENTION: INNOVATIONS ACROSS PRECISION MEDICINE2. EMERGING APTAMER DIAGNOSTICS: NEXT GEN POINT-OF-CARE (POC) TECHNOLOGY3. ROLE OF APTAMERS IN MOLECULAR MEDICINE4. CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR) AND BEYOND: REVOLUTIONIZING PRECISION MEDICINE AND GENETIC THERAPIES5. BIOSIMILARS IN CONTEMPORARY MEDICINE: FROM MOLECULAR DESIGN TO GLOBAL CLINICAL TRANSLATION6. SWEET SITE OF RNA : DISCOVERY AND IMPLICATION OF GLYCO RNA IN HEALTH AND DISEASE7. THE ROLE OF ER STRESS IN DISEASE AND IN THERAPEUTIC INTERACTIONSECTION 2: POTENTIAL OF STEM CELLS AND REGENERATIVE MEDICINE8. ADULT STEM CELLS AND APPLICATIONS9. EMBRYONIC STEM CELL RESEARCH: SCIENTIFIC ADVANCES AND BIOETHICAL CHALLENGES10. ORGANOIDS AND LAB-GROWN TISSUES: A NEW FRONTIER IN DISEASE MODELING AND REGENERATIVE MEDICINE11. 3D BIOPRINTING AND TISSUE ENGINEERING: BUILDING THE FUTURE OF TRANSPLANTATION12. ADVANCEMENTS IN HUMAN-BASED BIOMATERIALS FOR 3D BIOPRINTING TECHNOLOGIES13. POTENTIAL ROLE OF 3D-BIOPRINTING OF RECAPITULATED ORGANS AND TISSUES IN MODERN MEDICINE: AN OVERVIEW OF CARDIOVASCULAR DISEASES, CANCER, AND NON-CANCER APPLICATIONSSECTION 3: ARTIFICIAL INTELLIGENCE & MACHINE LEARNING IN HEALTHCARE14. ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN MICROBIAL DECIPHERING15. ARTIFICIAL INTELLIGENCE IN CLINICAL DIAGNOSTICS AND DECISION MAKING16. MODELING AND PREDICTING TO UNDERSTAND INFECTIOUS DISEASE TRANSMISSION17. THE FUTURE OF HEALING: AI-DRIVEN PRECISION MEDICINE FOR PERSONALIZED HEALTH CARE18. MOLECULAR EPIDEMIOLOGICAL APPROACH IN DISEASE MANAGEMENTSECTION 4: MOLECULAR INSIGHTS AND ADVANCED THERAPEUTICS IN DISEASE MANAGEMENT19. MAPPING MECHANISMS OF METASTASIS AND METABOLISM: ADVANCES IN UNDERSTANDING THE COMPLEXITY OF THETUMOR MICROENVIRONMENT20. MOLECULAR PATHOPHYSIOLOGY OF STROKE: MECHANISTIC INSIGHTS, BIOMARKERS, AND EMERGING THERAPEUTIC TARGETS21. PHARMACOTHERAPY OF HEART FAILURE: CURRENT TRENDS AND FUTURE DIRECTIONS22. MOLECULAR INTERVENTIONS IN HEART FAILURE: GENE EDITING AND GENE THERAPY23. ARRHYTHMIA-INDUCED SUDDEN CARDIAC DEATH: INSIGHTS AND PROSPECTS ON PATHOPHYSIOLOGY, BIOMARKERS, AND THERAPEUTIC STRATEGIES24. ADVANCED STRATEGIES FOR DETECTION AND TREATMENT OF HIGH-RISK ATHEROSCLEROTIC PLAQUES: THE ROLE OF SINGLE-CELL RNA SEQUENCINGSECTION 5: NANOTECHNOLOGY AND BIOMATERIALS IN MODERN MEDICINE25. PIONEERING ALZHEIMER'S DISEASE THERAPIES: INSIGHTS INTO PRECISION MEDICINE, NANOTHERAPEUTICS, AND STEM CELL INNOVATIONS26. EVOLVING PARADIGMS IN ALZHEIMER'S DISEASE: FROM PATHOGENESIS TO PRECISION THERAPIESSECTION 6: MICROBIOME, MENTAL HEALTH, AND INTEGRATIVE DISEASE MANAGEMENT27. MICROBIOME MEDICINE: THE GUT-IMMUNE-BRAIN AXIS IN HEALTH AND DISEASE28. THE CRUCIAL ROLES OF GUT MICROBIOTA IN THE DEVELOPMENT OF NON-COMMUNICABLE DISEASES WITH SPECIAL FOCUS ON THE EFFICACY OF PROBIOTICS AND BOVINE COLOSTRUM IN THE MANAGEMENT OF GASTROINTESTINAL DISORDERS IN ADULTS AND CHILDREN29. THE PATHOPHYSIOLOGICAL RELATIONSHIP BETWEEN DIABETES MELLITUS AND ALZHEIMER’S DISEASE AND MANAGEMENT WITH HERBAL REMEDIES: AN OVERVIEW OF PRECLINICAL AND CLINICAL STUDIES.30. EPIGENOME, NUTRIGENOME: IMPLICATIONS IN EVOLUTION OF TYPE 2 DIABETES31. INSIGHTS INTO THE COMPLEXITIES OF DEMENTIA: DIAGNOSIS, THERAPEUTICS AND CURRENT RESEARCH32. COGNITIVE DECLINE AND DEMENTIA IN ELDERLY HUMANS: HOLISTIC APPROACHES FOR THE PREVENTION AND MANAGEMENT OF NEURODEGENERATIVE DISEASES AND PSYCHIATRIC DISORDERS33. REVOLUTIONIZING DENTAL CARE: A NEW ERA OF PRECISION, PERSONALIZATION, AND INNOVATION34. OSTEOPOROSIS AS A PUBLIC HEALTH PROBLEM35. INTEGRATIVE MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) THROUGH YOGIC INTERVENTIONS36. CHALLENGES IN THE EARLY DIAGNOSIS OF RESPIRATORY DISEASES AND POSSIBLE INTERVENTIONS37. PRECISION MEDICINE IN ACUTE AND CHRONIC PANCREATITIS38. KIDNEY DISEASE – INNOVATIONS AND SOLUTIONS39. PATHOPHYSIOLOGY OF CHRONIC KIDNEY DISEASE: EPIDEMIOLOGY, DIAGNOSTICBIOMARKERS, AND MANAGEMENT WITH PROBIOTICS AND PREBIOTICS40. CURRENT TRENDS AND CHALLENGES IN REPRODUCTIVE HEALTH ACROSS GENDERS41. MALE BREAST CANCER: RARELY KNOWN DISEASERANBIR C. SOBTI SR. AND JAGMOHAN SINGHVOLUME 2: STRATEGIES FOR COMBATING DISEASES THROUGH NEW THERAPEUTICS, DRUG DEVELOPMENT, NUTRITIONAL APPROACHES, NUTRITION, AND HOLISTIC THERAPIESSECTION 1: INNOVATIONS IN DRUG DISCOVERY, DELIVERY SYSTEMS, AND REPURPOSING42. CARRAGEENAN AND FUCOIDAN-BASED DELIVERY SYSTEMS FOR ORAL DELIVERY OF POLYPHENOLS: A REVIEW43. RECENT DEVELOPMENTS AND EMERGING TRENDS IN DRUG DISCOVERY44. EXPLORING NEW APPLICATIONS OF EXISTING DRUGS IN CANCER THERAPY45. INNOVATIONS IN NANOTECHNOLOGY FOR TARGETED DRUG DELIVERY IN CANCER PATIENTS46. NANOTECHNOLOGY-STEERED APPROACHES IN THE FIELD OF PHYTOPHARMACEUTICALS: ENHANCED BIOAVAILABILITY, THERAPEUTIC VALUE AND SITE-SPECIFIC TARGETING47. NANOMATERIALS: TYPES, CHARACTERIZATION METHODS, MECHANISMS AS ANTIMICROBIALS- A REVIEW48. NANOMATERIAL AS ANTI-MALARIAL DRUG CARRIERS FOR THE EFFECTIVE TREATMENT OF MALARIA49. COMPOSITE LRP AND VGG NETWORKS FOR BRAIN TUMOR ANALYSIS50. VOL 2, CH 9: COMPARATIVE ANALYSIS OF CNN AND TRANSFORMER ARCHITECTURES FOR MELANOMA DETECTION USING DERMOSCOPIC IMAGES51. VOL 2, CH 10: BIONANOCOMPOSITES IN ANTI-INFLAMMATORY ACTIVITY52. VOL 2, CH 11: SCANDIUM-LABELED PET RADIOPHARMACEUTICALS IN RADIOTHERANOSTICS: PRECLINICAL INSIGHTS AND CLINICAL PERSPECTIVESSECTION 2: ADVANCES IN VACCINES AND IMMUNOTHERAPIES53. EMERGING VACCINE TECHNOLOGIES: REVOLUTIONIZING THE PREVENTION OF PANDEMICS54. MRNA VACCINE TECHNOLOGY: THE NEW ERA OF INFECTIOUS DISEASE CONTROL AND CANCER IMMUNOTHERAPY55. VACCINE-BASED THERAPEUTIC INTERVENTIONS IN UVEAL MELANOMA MANAGEMENT: A CONCEPTUAL REVIEW56. EDIBLE VACCINES AND HUMAN HEALTH: REALITY AND PREDICTIONS57. TYPHOID VACCINES: THE ROADWAY TO EFFECTIVE CONTROL58. REWIRING THE IMMUNE SYSTEM: ROLE OF CAR-T CELLS IN CANCER TREATMENT59. TUNING YAYS-NAYS FOR CHIMERIC ANTIGEN RECEPTOR BASED CANCER IMMUNOTHERAPY EFFICACYSECTION 3 : FUNCTIONAL FOODS, NUTRITION, AND CHRONIC DISEASE MANAGEMENT60. PALUDICULTURE: A SOURCE OF POLYPHENOLS FOR CLINICAL NUTRITION AND FAVOURABLE CARBON FOOTPRINT61. SECONDARY METABOLITES LIKE FLAVONOIDS USED FOR CANCER TREATMENT: RECENT TRENDS AND FUTURE PERSPECTIVES62. DEVELOPMENT OF PHYTOCHEMICAL-BASED FOOD PRODUCTS FOR THE PREVENTION AND MANAGEMENT OF CHRONIC DISEASES63. THE FUTURE OF PROTEIN SECURITY: AN OVERVIEW OF POTENTIAL ALTERNATIVES TO NON-ANIMAL PROTEIN SOURCES64. THE FARM-TO-FORK STRATEGY: FROM PRODUCTION AND MANUFACTURING TO SUSTAINABLE HEALTHYFOOD SUPPLY65. THE FUTURE OF FOODS: ALTERNATIVE PROTEIN SOURCES66. NUTRITIONAL AND THERAPEUTIC BENEFITS OF MILLETS IN HEALTH AND DISEASE: A SYSTEMATIC REVIEW FOR PREVENTING NON-COMMUNICABLE DISEASES67. THE ROLE OF FUNCTIONAL FOODS, PLANT PROTEINS, AND OILSEEDS IN NUTRITIONAL STRATEGIES FOR DISEASE PREVENTION: AN OVERVIEW68. PROBIOTICS FROM TRADITIONAL AND CLINICAL PROSPECTIVES69. THE ROLE OF PROBIOTICS IN CANCER PREVENTION AND TREATMENTSECTION 4 : MARINE AND MICROBIAL RESOURCES FOR HEALTH AND WELL-BEING70. HARVESTING THE BOUNTY OF THE SEAS FOR SUSTAINABLE FOOD SUPPLY, DIETARY SUPPLEMENTS, NUTRACEUTICALS, AND MEDICINAL INGREDIENTS71. GLOBALLY SUSTAINABLE PRODUCTS OF SEA ORIGIN FOR HEALTH PROMOTION AND DISEASE PREVENTION: AN OVERVIEW ON THE DISCOVERY OF MARINE-DERIVED FOODS AND NUTRACEUTICALSSECTION 5 : HERBAL MEDICINE, NATURAL COMPOUNDS, AND INTEGRATIVE THERAPIES72. HERBAL INTERVENTIONS FOR THE TREATMENT OF ALCOHOL ADDICTION73. NATURAL PRODUCTS-BASED NIOSOMAL ANTI-CANCER FORMULATIONS: RECENT TRENDS AND FUTURE PERSPECTIVES74. BIOLOGICAL ACTIVITIES OF ERIGERON ANNUS AND NERIUM INDICUM75. BIOLOGICAL ACTIVITIES OF RUMEX NEPALENSIS AND HEDYCHIUM SPICATUM ERIGERON ANNUS AND NERIUM INDICUM76. AN OVERVIEW OF THE PAST, PRESENT, AND FUTURE OF NATURAL ANTICANCER MEDICINES DERIVED FROM PLANTS AND MARINE SOURCES: EFFICACY, SAFETY, AND MECHANISMS

Dr. Ranbir Chander (RC) Sobti is Emeritus Professor at Punjab University, Chandigarh, and Honorary Scientist at the Indian National Science Academy. He started his career as a cytogeneticist and progressed to molecular biology and disease processes of cancer, COPD, AIDS, metabolic syndrome, and kidney diseases. He is a Fellow of the Third World Academy of Sciences, National Academy of Sciences India, Indian National Science Academy, National Academy of Medical Sciences, National Academy of Agricultural Sciences, Canadian Academy of Cardiovascular Diseases Royal Society of biology and international Association of Cancer Research. Dr. Sobti has participated in several book projects, including Elsevier’s Advances in Animal Experimentation and Modeling; Biomarkers in Cancer Detection and Monitoring of Therapeutics; Molecular Medicine and Biomedical Research in the Era of Precision Medicine; One Planet, One Health, One Future; Probiotics; and Public and Environmental Health. Aastha Sobti is a Doctoral student at the Department of Immunotechnology at Lund University, Sweden. Her research areas interests include translational medicine, clinical dentistry, cancer immunology, biomarkers, diagnostics and medical oncology. Aastha Sobti has written two books with Elsevier: "Biomarkers in Cancer Detection and Monitoring of Therapeutics" (2023) and Molecular Medicine and Biomedical Research in the Era of Precision Medicine (2025). Dr. Jagmohan Singh holds a Ph.D. in Biotechnology and Cancer Genomics from Punjab University, Chandigarh, India. He is currently serving as an adjunct faculty in Anatomy and Physiology at Thomas Jefferson University in Philadelphia, Pennsylvania. He has made significant contribution in Gastric Physiology and Pharmacology. His current research focus is on cancer immunotherapy and vaccine development against cancer recurrence. Dr. Singh's teaching and research experience has provided him with valuable insights into reviewing and editing scientific papers, review articles and book chapters, with diverse scientific aims. His research findings have been published in numerous internationally reputed journals. He has also made substantial contributions to cancer immunotherapy, including vaccine production, quality control, and clinical trials. As a multifaceted professional with a robust background in research, education, and administration, Dr. Singh’s contributions will be highly insightful to fulfilling the purpose of this book. Harpal S. Buttar, PhD, is Adjunct Professor in the Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of Ottawa, Canada, and also serves as Visiting Professor at Guru Nanak Dev University, India, and Honorary Professor at Amity University, India. He previously worked for more than four decades as a Senior Research Scientist and Assessment Officer in the Therapeutic Products Directorate of Health Canada. His research and professional interests include pharmacology, nutrition, functional foods, dietary interventions, lifestyle approaches to the prevention of cardiovascular disease, obesity, and diabetes, and the safety of drug interactions with herbal products and fruit juices. Dr. Buttar has contributed extensively to biomedical research through scholarly publications, book chapters, and international collaborations. He has served on the editorial boards of scientific journals, acted as an external examiner for postgraduate research degrees, and delivered invited lectures and seminars internationally. He is a Fellow of the International College of Nutrition and the International Academy of Cardiovascular Sciences.

Select Guide Rating

• VOLUME 1: INTEGRATING MODERN HEALTH TECHNOLOGIES AND TRADITIONAL THERAPIES TO PROMOTE GOOD HEALTHSECTION 1: BIOTECHNOLOGICAL INNOVATIONS FOR SUSTAINABLE DEVELOPMENT TOWARDS GOOD HEALTH CARE SYSTEM1. ADVANCED TECHNOLOGIES FOR DISEASE INTERVENTION: INNOVATIONS ACROSS PRECISION MEDICINE2. EMERGING APTAMER DIAGNOSTICS: NEXT GEN POINT-OF-CARE (POC) TECHNOLOGY3. ROLE OF APTAMERS IN MOLECULAR MEDICINE4. CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR) AND BEYOND: REVOLUTIONIZING PRECISION MEDICINE AND GENETIC THERAPIES5. BIOSIMILARS IN CONTEMPORARY MEDICINE: FROM MOLECULAR DESIGN TO GLOBAL CLINICAL TRANSLATION6. SWEET SITE OF RNA : DISCOVERY AND IMPLICATION OF GLYCO RNA IN HEALTH AND DISEASE7. THE ROLE OF ER STRESS IN DISEASE AND IN THERAPEUTIC INTERACTIONSECTION 2: POTENTIAL OF STEM CELLS AND REGENERATIVE MEDICINE8. ADULT STEM CELLS AND APPLICATIONS9. EMBRYONIC STEM CELL RESEARCH: SCIENTIFIC ADVANCES AND BIOETHICAL CHALLENGES10. ORGANOIDS AND LAB-GROWN TISSUES: A NEW FRONTIER IN DISEASE MODELING AND REGENERATIVE MEDICINE11. 3D BIOPRINTING AND TISSUE ENGINEERING: BUILDING THE FUTURE OF TRANSPLANTATION12. ADVANCEMENTS IN HUMAN-BASED BIOMATERIALS FOR 3D BIOPRINTING TECHNOLOGIES13. POTENTIAL ROLE OF 3D-BIOPRINTING OF RECAPITULATED ORGANS AND TISSUES IN MODERN MEDICINE: AN OVERVIEW OF CARDIOVASCULAR DISEASES, CANCER, AND NON-CANCER APPLICATIONSSECTION 3: ARTIFICIAL INTELLIGENCE & MACHINE LEARNING IN HEALTHCARE14. ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN MICROBIAL DECIPHERING15. ARTIFICIAL INTELLIGENCE IN CLINICAL DIAGNOSTICS AND DECISION MAKING16. MODELING AND PREDICTING TO UNDERSTAND INFECTIOUS DISEASE TRANSMISSION17. THE FUTURE OF HEALING: AI-DRIVEN PRECISION MEDICINE FOR PERSONALIZED HEALTH CARE18. MOLECULAR EPIDEMIOLOGICAL APPROACH IN DISEASE MANAGEMENTSECTION 4: MOLECULAR INSIGHTS AND ADVANCED THERAPEUTICS IN DISEASE MANAGEMENT19. MAPPING MECHANISMS OF METASTASIS AND METABOLISM: ADVANCES IN UNDERSTANDING THE COMPLEXITY OF THETUMOR MICROENVIRONMENT20. MOLECULAR PATHOPHYSIOLOGY OF STROKE: MECHANISTIC INSIGHTS, BIOMARKERS, AND EMERGING THERAPEUTIC TARGETS21. PHARMACOTHERAPY OF HEART FAILURE: CURRENT TRENDS AND FUTURE DIRECTIONS22. MOLECULAR INTERVENTIONS IN HEART FAILURE: GENE EDITING AND GENE THERAPY23. ARRHYTHMIA-INDUCED SUDDEN CARDIAC DEATH: INSIGHTS AND PROSPECTS ON PATHOPHYSIOLOGY, BIOMARKERS, AND THERAPEUTIC STRATEGIES24. ADVANCED STRATEGIES FOR DETECTION AND TREATMENT OF HIGH-RISK ATHEROSCLEROTIC PLAQUES: THE ROLE OF SINGLE-CELL RNA SEQUENCINGSECTION 5: NANOTECHNOLOGY AND BIOMATERIALS IN MODERN MEDICINE25. PIONEERING ALZHEIMER'S DISEASE THERAPIES: INSIGHTS INTO PRECISION MEDICINE, NANOTHERAPEUTICS, AND STEM CELL INNOVATIONS26. EVOLVING PARADIGMS IN ALZHEIMER'S DISEASE: FROM PATHOGENESIS TO PRECISION THERAPIESSECTION 6: MICROBIOME, MENTAL HEALTH, AND INTEGRATIVE DISEASE MANAGEMENT27. MICROBIOME MEDICINE: THE GUT-IMMUNE-BRAIN AXIS IN HEALTH AND DISEASE28. THE CRUCIAL ROLES OF GUT MICROBIOTA IN THE DEVELOPMENT OF NON-COMMUNICABLE DISEASES WITH SPECIAL FOCUS ON THE EFFICACY OF PROBIOTICS AND BOVINE COLOSTRUM IN THE MANAGEMENT OF GASTROINTESTINAL DISORDERS IN ADULTS AND CHILDREN29. THE PATHOPHYSIOLOGICAL RELATIONSHIP BETWEEN DIABETES MELLITUS AND ALZHEIMER’S DISEASE AND MANAGEMENT WITH HERBAL REMEDIES: AN OVERVIEW OF PRECLINICAL AND CLINICAL STUDIES.30. EPIGENOME, NUTRIGENOME: IMPLICATIONS IN EVOLUTION OF TYPE 2 DIABETES31. INSIGHTS INTO THE COMPLEXITIES OF DEMENTIA: DIAGNOSIS, THERAPEUTICS AND CURRENT RESEARCH32. COGNITIVE DECLINE AND DEMENTIA IN ELDERLY HUMANS: HOLISTIC APPROACHES FOR THE PREVENTION AND MANAGEMENT OF NEURODEGENERATIVE DISEASES AND PSYCHIATRIC DISORDERS33. REVOLUTIONIZING DENTAL CARE: A NEW ERA OF PRECISION, PERSONALIZATION, AND INNOVATION34. OSTEOPOROSIS AS A PUBLIC HEALTH PROBLEM35. INTEGRATIVE MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) THROUGH YOGIC INTERVENTIONS36. CHALLENGES IN THE EARLY DIAGNOSIS OF RESPIRATORY DISEASES AND POSSIBLE INTERVENTIONS37. PRECISION MEDICINE IN ACUTE AND CHRONIC PANCREATITIS38. KIDNEY DISEASE – INNOVATIONS AND SOLUTIONS39. PATHOPHYSIOLOGY OF CHRONIC KIDNEY DISEASE: EPIDEMIOLOGY, DIAGNOSTICBIOMARKERS, AND MANAGEMENT WITH PROBIOTICS AND PREBIOTICS40. CURRENT TRENDS AND CHALLENGES IN REPRODUCTIVE HEALTH ACROSS GENDERS41. MALE BREAST CANCER: RARELY KNOWN DISEASERANBIR C. SOBTI SR. AND JAGMOHAN SINGHVOLUME 2: STRATEGIES FOR COMBATING DISEASES THROUGH NEW THERAPEUTICS, DRUG DEVELOPMENT, NUTRITIONAL APPROACHES, NUTRITION, AND HOLISTIC THERAPIESSECTION 1: INNOVATIONS IN DRUG DISCOVERY, DELIVERY SYSTEMS, AND REPURPOSING42. CARRAGEENAN AND FUCOIDAN-BASED DELIVERY SYSTEMS FOR ORAL DELIVERY OF POLYPHENOLS: A REVIEW43. RECENT DEVELOPMENTS AND EMERGING TRENDS IN DRUG DISCOVERY44. EXPLORING NEW APPLICATIONS OF EXISTING DRUGS IN CANCER THERAPY45. INNOVATIONS IN NANOTECHNOLOGY FOR TARGETED DRUG DELIVERY IN CANCER PATIENTS46. NANOTECHNOLOGY-STEERED APPROACHES IN THE FIELD OF PHYTOPHARMACEUTICALS: ENHANCED BIOAVAILABILITY, THERAPEUTIC VALUE AND SITE-SPECIFIC TARGETING47. NANOMATERIALS: TYPES, CHARACTERIZATION METHODS, MECHANISMS AS ANTIMICROBIALS- A REVIEW48. NANOMATERIAL AS ANTI-MALARIAL DRUG CARRIERS FOR THE EFFECTIVE TREATMENT OF MALARIA49. COMPOSITE LRP AND VGG NETWORKS FOR BRAIN TUMOR ANALYSIS50. VOL 2, CH 9: COMPARATIVE ANALYSIS OF CNN AND TRANSFORMER ARCHITECTURES FOR MELANOMA DETECTION USING DERMOSCOPIC IMAGES51. VOL 2, CH 10: BIONANOCOMPOSITES IN ANTI-INFLAMMATORY ACTIVITY52. VOL 2, CH 11: SCANDIUM-LABELED PET RADIOPHARMACEUTICALS IN RADIOTHERANOSTICS: PRECLINICAL INSIGHTS AND CLINICAL PERSPECTIVESSECTION 2: ADVANCES IN VACCINES AND IMMUNOTHERAPIES53. EMERGING VACCINE TECHNOLOGIES: REVOLUTIONIZING THE PREVENTION OF PANDEMICS54. MRNA VACCINE TECHNOLOGY: THE NEW ERA OF INFECTIOUS DISEASE CONTROL AND CANCER IMMUNOTHERAPY55. VACCINE-BASED THERAPEUTIC INTERVENTIONS IN UVEAL MELANOMA MANAGEMENT: A CONCEPTUAL REVIEW56. EDIBLE VACCINES AND HUMAN HEALTH: REALITY AND PREDICTIONS57. TYPHOID VACCINES: THE ROADWAY TO EFFECTIVE CONTROL58. REWIRING THE IMMUNE SYSTEM: ROLE OF CAR-T CELLS IN CANCER TREATMENT59. TUNING YAYS-NAYS FOR CHIMERIC ANTIGEN RECEPTOR BASED CANCER IMMUNOTHERAPY EFFICACYSECTION 3 : FUNCTIONAL FOODS, NUTRITION, AND CHRONIC DISEASE MANAGEMENT60. PALUDICULTURE: A SOURCE OF POLYPHENOLS FOR CLINICAL NUTRITION AND FAVOURABLE CARBON FOOTPRINT61. SECONDARY METABOLITES LIKE FLAVONOIDS USED FOR CANCER TREATMENT: RECENT TRENDS AND FUTURE PERSPECTIVES62. DEVELOPMENT OF PHYTOCHEMICAL-BASED FOOD PRODUCTS FOR THE PREVENTION AND MANAGEMENT OF CHRONIC DISEASES63. THE FUTURE OF PROTEIN SECURITY: AN OVERVIEW OF POTENTIAL ALTERNATIVES TO NON-ANIMAL PROTEIN SOURCES64. THE FARM-TO-FORK STRATEGY: FROM PRODUCTION AND MANUFACTURING TO SUSTAINABLE HEALTHYFOOD SUPPLY65. THE FUTURE OF FOODS: ALTERNATIVE PROTEIN SOURCES66. NUTRITIONAL AND THERAPEUTIC BENEFITS OF MILLETS IN HEALTH AND DISEASE: A SYSTEMATIC REVIEW FOR PREVENTING NON-COMMUNICABLE DISEASES67. THE ROLE OF FUNCTIONAL FOODS, PLANT PROTEINS, AND OILSEEDS IN NUTRITIONAL STRATEGIES FOR DISEASE PREVENTION: AN OVERVIEW68. PROBIOTICS FROM TRADITIONAL AND CLINICAL PROSPECTIVES69. THE ROLE OF PROBIOTICS IN CANCER PREVENTION AND TREATMENTSECTION 4 : MARINE AND MICROBIAL RESOURCES FOR HEALTH AND WELL-BEING70. HARVESTING THE BOUNTY OF THE SEAS FOR SUSTAINABLE FOOD SUPPLY, DIETARY SUPPLEMENTS, NUTRACEUTICALS, AND MEDICINAL INGREDIENTS71. GLOBALLY SUSTAINABLE PRODUCTS OF SEA ORIGIN FOR HEALTH PROMOTION AND DISEASE PREVENTION: AN OVERVIEW ON THE DISCOVERY OF MARINE-DERIVED FOODS AND NUTRACEUTICALSSECTION 5 : HERBAL MEDICINE, NATURAL COMPOUNDS, AND INTEGRATIVE THERAPIES72. HERBAL INTERVENTIONS FOR THE TREATMENT OF ALCOHOL ADDICTION73. NATURAL PRODUCTS-BASED NIOSOMAL ANTI-CANCER FORMULATIONS: RECENT TRENDS AND FUTURE PERSPECTIVES74. BIOLOGICAL ACTIVITIES OF ERIGERON ANNUS AND NERIUM INDICUM75. BIOLOGICAL ACTIVITIES OF RUMEX NEPALENSIS AND HEDYCHIUM SPICATUM ERIGERON ANNUS AND NERIUM INDICUM76. AN OVERVIEW OF THE PAST, PRESENT, AND FUTURE OF NATURAL ANTICANCER MEDICINES DERIVED FROM PLANTS AND MARINE SOURCES: EFFICACY, SAFETY, AND MECHANISMS

Dr. Ranbir Chander (RC) Sobti is Emeritus Professor at Punjab University, Chandigarh, and Honorary Scientist at the Indian National Science Academy. He started his career as a cytogeneticist and progressed to molecular biology and disease processes of cancer, COPD, AIDS, metabolic syndrome, and kidney diseases. He is a Fellow of the Third World Academy of Sciences, National Academy of Sciences India, Indian National Science Academy, National Academy of Medical Sciences, National Academy of Agricultural Sciences, Canadian Academy of Cardiovascular Diseases Royal Society of biology and international Association of Cancer Research. Dr. Sobti has participated in several book projects, including Elsevier’s Advances in Animal Experimentation and Modeling; Biomarkers in Cancer Detection and Monitoring of Therapeutics; Molecular Medicine and Biomedical Research in the Era of Precision Medicine; One Planet, One Health, One Future; Probiotics; and Public and Environmental Health. Aastha Sobti is a Doctoral student at the Department of Immunotechnology at Lund University, Sweden. Her research areas interests include translational medicine, clinical dentistry, cancer immunology, biomarkers, diagnostics and medical oncology. Aastha Sobti has written two books with Elsevier: "Biomarkers in Cancer Detection and Monitoring of Therapeutics" (2023) and Molecular Medicine and Biomedical Research in the Era of Precision Medicine (2025). Dr. Jagmohan Singh holds a Ph.D. in Biotechnology and Cancer Genomics from Punjab University, Chandigarh, India. He is currently serving as an adjunct faculty in Anatomy and Physiology at Thomas Jefferson University in Philadelphia, Pennsylvania. He has made significant contribution in Gastric Physiology and Pharmacology. His current research focus is on cancer immunotherapy and vaccine development against cancer recurrence. Dr. Singh's teaching and research experience has provided him with valuable insights into reviewing and editing scientific papers, review articles and book chapters, with diverse scientific aims. His research findings have been published in numerous internationally reputed journals. He has also made substantial contributions to cancer immunotherapy, including vaccine production, quality control, and clinical trials. As a multifaceted professional with a robust background in research, education, and administration, Dr. Singh’s contributions will be highly insightful to fulfilling the purpose of this book. Harpal S. Buttar, PhD, is Adjunct Professor in the Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of Ottawa, Canada, and also serves as Visiting Professor at Guru Nanak Dev University, India, and Honorary Professor at Amity University, India. He previously worked for more than four decades as a Senior Research Scientist and Assessment Officer in the Therapeutic Products Directorate of Health Canada. His research and professional interests include pharmacology, nutrition, functional foods, dietary interventions, lifestyle approaches to the prevention of cardiovascular disease, obesity, and diabetes, and the safety of drug interactions with herbal products and fruit juices. Dr. Buttar has contributed extensively to biomedical research through scholarly publications, book chapters, and international collaborations. He has served on the editorial boards of scientific journals, acted as an external examiner for postgraduate research degrees, and delivered invited lectures and seminars internationally. He is a Fellow of the International College of Nutrition and the International Academy of Cardiovascular Sciences.

Select Guide Rating

• VOLUME 1: INTEGRATING MODERN HEALTH TECHNOLOGIES AND TRADITIONAL THERAPIES TO PROMOTE GOOD HEALTHSECTION 1: BIOTECHNOLOGICAL INNOVATIONS FOR SUSTAINABLE DEVELOPMENT TOWARDS GOOD HEALTH CARE SYSTEM1. ADVANCED TECHNOLOGIES FOR DISEASE INTERVENTION: INNOVATIONS ACROSS PRECISION MEDICINE2. EMERGING APTAMER DIAGNOSTICS: NEXT GEN POINT-OF-CARE (POC) TECHNOLOGY3. ROLE OF APTAMERS IN MOLECULAR MEDICINE4. CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR) AND BEYOND: REVOLUTIONIZING PRECISION MEDICINE AND GENETIC THERAPIES5. BIOSIMILARS IN CONTEMPORARY MEDICINE: FROM MOLECULAR DESIGN TO GLOBAL CLINICAL TRANSLATION6. SWEET SITE OF RNA : DISCOVERY AND IMPLICATION OF GLYCO RNA IN HEALTH AND DISEASE7. THE ROLE OF ER STRESS IN DISEASE AND IN THERAPEUTIC INTERACTIONSECTION 2: POTENTIAL OF STEM CELLS AND REGENERATIVE MEDICINE8. ADULT STEM CELLS AND APPLICATIONS9. EMBRYONIC STEM CELL RESEARCH: SCIENTIFIC ADVANCES AND BIOETHICAL CHALLENGES10. ORGANOIDS AND LAB-GROWN TISSUES: A NEW FRONTIER IN DISEASE MODELING AND REGENERATIVE MEDICINE11. 3D BIOPRINTING AND TISSUE ENGINEERING: BUILDING THE FUTURE OF TRANSPLANTATION12. ADVANCEMENTS IN HUMAN-BASED BIOMATERIALS FOR 3D BIOPRINTING TECHNOLOGIES13. POTENTIAL ROLE OF 3D-BIOPRINTING OF RECAPITULATED ORGANS AND TISSUES IN MODERN MEDICINE: AN OVERVIEW OF CARDIOVASCULAR DISEASES, CANCER, AND NON-CANCER APPLICATIONSSECTION 3: ARTIFICIAL INTELLIGENCE & MACHINE LEARNING IN HEALTHCARE14. ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN MICROBIAL DECIPHERING15. ARTIFICIAL INTELLIGENCE IN CLINICAL DIAGNOSTICS AND DECISION MAKING16. MODELING AND PREDICTING TO UNDERSTAND INFECTIOUS DISEASE TRANSMISSION17. THE FUTURE OF HEALING: AI-DRIVEN PRECISION MEDICINE FOR PERSONALIZED HEALTH CARE18. MOLECULAR EPIDEMIOLOGICAL APPROACH IN DISEASE MANAGEMENTSECTION 4: MOLECULAR INSIGHTS AND ADVANCED THERAPEUTICS IN DISEASE MANAGEMENT19. MAPPING MECHANISMS OF METASTASIS AND METABOLISM: ADVANCES IN UNDERSTANDING THE COMPLEXITY OF THETUMOR MICROENVIRONMENT20. MOLECULAR PATHOPHYSIOLOGY OF STROKE: MECHANISTIC INSIGHTS, BIOMARKERS, AND EMERGING THERAPEUTIC TARGETS21. PHARMACOTHERAPY OF HEART FAILURE: CURRENT TRENDS AND FUTURE DIRECTIONS22. MOLECULAR INTERVENTIONS IN HEART FAILURE: GENE EDITING AND GENE THERAPY23. ARRHYTHMIA-INDUCED SUDDEN CARDIAC DEATH: INSIGHTS AND PROSPECTS ON PATHOPHYSIOLOGY, BIOMARKERS, AND THERAPEUTIC STRATEGIES24. ADVANCED STRATEGIES FOR DETECTION AND TREATMENT OF HIGH-RISK ATHEROSCLEROTIC PLAQUES: THE ROLE OF SINGLE-CELL RNA SEQUENCINGSECTION 5: NANOTECHNOLOGY AND BIOMATERIALS IN MODERN MEDICINE25. PIONEERING ALZHEIMER'S DISEASE THERAPIES: INSIGHTS INTO PRECISION MEDICINE, NANOTHERAPEUTICS, AND STEM CELL INNOVATIONS26. EVOLVING PARADIGMS IN ALZHEIMER'S DISEASE: FROM PATHOGENESIS TO PRECISION THERAPIESSECTION 6: MICROBIOME, MENTAL HEALTH, AND INTEGRATIVE DISEASE MANAGEMENT27. MICROBIOME MEDICINE: THE GUT-IMMUNE-BRAIN AXIS IN HEALTH AND DISEASE28. THE CRUCIAL ROLES OF GUT MICROBIOTA IN THE DEVELOPMENT OF NON-COMMUNICABLE DISEASES WITH SPECIAL FOCUS ON THE EFFICACY OF PROBIOTICS AND BOVINE COLOSTRUM IN THE MANAGEMENT OF GASTROINTESTINAL DISORDERS IN ADULTS AND CHILDREN29. THE PATHOPHYSIOLOGICAL RELATIONSHIP BETWEEN DIABETES MELLITUS AND ALZHEIMER’S DISEASE AND MANAGEMENT WITH HERBAL REMEDIES: AN OVERVIEW OF PRECLINICAL AND CLINICAL STUDIES.30. EPIGENOME, NUTRIGENOME: IMPLICATIONS IN EVOLUTION OF TYPE 2 DIABETES31. INSIGHTS INTO THE COMPLEXITIES OF DEMENTIA: DIAGNOSIS, THERAPEUTICS AND CURRENT RESEARCH32. COGNITIVE DECLINE AND DEMENTIA IN ELDERLY HUMANS: HOLISTIC APPROACHES FOR THE PREVENTION AND MANAGEMENT OF NEURODEGENERATIVE DISEASES AND PSYCHIATRIC DISORDERS33. REVOLUTIONIZING DENTAL CARE: A NEW ERA OF PRECISION, PERSONALIZATION, AND INNOVATION34. OSTEOPOROSIS AS A PUBLIC HEALTH PROBLEM35. INTEGRATIVE MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) THROUGH YOGIC INTERVENTIONS36. CHALLENGES IN THE EARLY DIAGNOSIS OF RESPIRATORY DISEASES AND POSSIBLE INTERVENTIONS37. PRECISION MEDICINE IN ACUTE AND CHRONIC PANCREATITIS38. KIDNEY DISEASE – INNOVATIONS AND SOLUTIONS39. PATHOPHYSIOLOGY OF CHRONIC KIDNEY DISEASE: EPIDEMIOLOGY, DIAGNOSTICBIOMARKERS, AND MANAGEMENT WITH PROBIOTICS AND PREBIOTICS40. CURRENT TRENDS AND CHALLENGES IN REPRODUCTIVE HEALTH ACROSS GENDERS41. MALE BREAST CANCER: RARELY KNOWN DISEASERANBIR C. SOBTI SR. AND JAGMOHAN SINGHVOLUME 2: STRATEGIES FOR COMBATING DISEASES THROUGH NEW THERAPEUTICS, DRUG DEVELOPMENT, NUTRITIONAL APPROACHES, NUTRITION, AND HOLISTIC THERAPIESSECTION 1: INNOVATIONS IN DRUG DISCOVERY, DELIVERY SYSTEMS, AND REPURPOSING42. CARRAGEENAN AND FUCOIDAN-BASED DELIVERY SYSTEMS FOR ORAL DELIVERY OF POLYPHENOLS: A REVIEW43. RECENT DEVELOPMENTS AND EMERGING TRENDS IN DRUG DISCOVERY44. EXPLORING NEW APPLICATIONS OF EXISTING DRUGS IN CANCER THERAPY45. INNOVATIONS IN NANOTECHNOLOGY FOR TARGETED DRUG DELIVERY IN CANCER PATIENTS46. NANOTECHNOLOGY-STEERED APPROACHES IN THE FIELD OF PHYTOPHARMACEUTICALS: ENHANCED BIOAVAILABILITY, THERAPEUTIC VALUE AND SITE-SPECIFIC TARGETING47. NANOMATERIALS: TYPES, CHARACTERIZATION METHODS, MECHANISMS AS ANTIMICROBIALS- A REVIEW48. NANOMATERIAL AS ANTI-MALARIAL DRUG CARRIERS FOR THE EFFECTIVE TREATMENT OF MALARIA49. COMPOSITE LRP AND VGG NETWORKS FOR BRAIN TUMOR ANALYSIS50. VOL 2, CH 9: COMPARATIVE ANALYSIS OF CNN AND TRANSFORMER ARCHITECTURES FOR MELANOMA DETECTION USING DERMOSCOPIC IMAGES51. VOL 2, CH 10: BIONANOCOMPOSITES IN ANTI-INFLAMMATORY ACTIVITY52. VOL 2, CH 11: SCANDIUM-LABELED PET RADIOPHARMACEUTICALS IN RADIOTHERANOSTICS: PRECLINICAL INSIGHTS AND CLINICAL PERSPECTIVESSECTION 2: ADVANCES IN VACCINES AND IMMUNOTHERAPIES53. EMERGING VACCINE TECHNOLOGIES: REVOLUTIONIZING THE PREVENTION OF PANDEMICS54. MRNA VACCINE TECHNOLOGY: THE NEW ERA OF INFECTIOUS DISEASE CONTROL AND CANCER IMMUNOTHERAPY55. VACCINE-BASED THERAPEUTIC INTERVENTIONS IN UVEAL MELANOMA MANAGEMENT: A CONCEPTUAL REVIEW56. EDIBLE VACCINES AND HUMAN HEALTH: REALITY AND PREDICTIONS57. TYPHOID VACCINES: THE ROADWAY TO EFFECTIVE CONTROL58. REWIRING THE IMMUNE SYSTEM: ROLE OF CAR-T CELLS IN CANCER TREATMENT59. TUNING YAYS-NAYS FOR CHIMERIC ANTIGEN RECEPTOR BASED CANCER IMMUNOTHERAPY EFFICACYSECTION 3 : FUNCTIONAL FOODS, NUTRITION, AND CHRONIC DISEASE MANAGEMENT60. PALUDICULTURE: A SOURCE OF POLYPHENOLS FOR CLINICAL NUTRITION AND FAVOURABLE CARBON FOOTPRINT61. SECONDARY METABOLITES LIKE FLAVONOIDS USED FOR CANCER TREATMENT: RECENT TRENDS AND FUTURE PERSPECTIVES62. DEVELOPMENT OF PHYTOCHEMICAL-BASED FOOD PRODUCTS FOR THE PREVENTION AND MANAGEMENT OF CHRONIC DISEASES63. THE FUTURE OF PROTEIN SECURITY: AN OVERVIEW OF POTENTIAL ALTERNATIVES TO NON-ANIMAL PROTEIN SOURCES64. THE FARM-TO-FORK STRATEGY: FROM PRODUCTION AND MANUFACTURING TO SUSTAINABLE HEALTHYFOOD SUPPLY65. THE FUTURE OF FOODS: ALTERNATIVE PROTEIN SOURCES66. NUTRITIONAL AND THERAPEUTIC BENEFITS OF MILLETS IN HEALTH AND DISEASE: A SYSTEMATIC REVIEW FOR PREVENTING NON-COMMUNICABLE DISEASES67. THE ROLE OF FUNCTIONAL FOODS, PLANT PROTEINS, AND OILSEEDS IN NUTRITIONAL STRATEGIES FOR DISEASE PREVENTION: AN OVERVIEW68. PROBIOTICS FROM TRADITIONAL AND CLINICAL PROSPECTIVES69. THE ROLE OF PROBIOTICS IN CANCER PREVENTION AND TREATMENTSECTION 4 : MARINE AND MICROBIAL RESOURCES FOR HEALTH AND WELL-BEING70. HARVESTING THE BOUNTY OF THE SEAS FOR SUSTAINABLE FOOD SUPPLY, DIETARY SUPPLEMENTS, NUTRACEUTICALS, AND MEDICINAL INGREDIENTS71. GLOBALLY SUSTAINABLE PRODUCTS OF SEA ORIGIN FOR HEALTH PROMOTION AND DISEASE PREVENTION: AN OVERVIEW ON THE DISCOVERY OF MARINE-DERIVED FOODS AND NUTRACEUTICALSSECTION 5 : HERBAL MEDICINE, NATURAL COMPOUNDS, AND INTEGRATIVE THERAPIES72. HERBAL INTERVENTIONS FOR THE TREATMENT OF ALCOHOL ADDICTION73. NATURAL PRODUCTS-BASED NIOSOMAL ANTI-CANCER FORMULATIONS: RECENT TRENDS AND FUTURE PERSPECTIVES74. BIOLOGICAL ACTIVITIES OF ERIGERON ANNUS AND NERIUM INDICUM75. BIOLOGICAL ACTIVITIES OF RUMEX NEPALENSIS AND HEDYCHIUM SPICATUM ERIGERON ANNUS AND NERIUM INDICUM76. AN OVERVIEW OF THE PAST, PRESENT, AND FUTURE OF NATURAL ANTICANCER MEDICINES DERIVED FROM PLANTS AND MARINE SOURCES: EFFICACY, SAFETY, AND MECHANISMS